Preclinical development of T-cell receptor-engineered T-cell therapy targeting the 5T4 tumor antigen on renal cell carcinoma

Overview of attention for article published in Cancer Immunology, Immunotherapy, November 2019

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

twitter: 2 X users

patent: 1 patent

Readers on

mendeley: 42 Mendeley

Summary X Patents

So far, Altmetric has seen 1 patent that references this research output.

CHIMERIC, TRANSMEMBRANE PROTEINS WITH BIDIRECTIONAL SIGNALLING ACTIVITY

Application WO-2022136681-A1

World Intellectual Property Organisation (WIPO)